Russia has said it will complete early-stage trials of a second COVID-19 vaccine candidate by the end of this month. Human trials of the vaccine called EpiVacCorona started in July.

Subscribe to our channel here: [ Ссылка ]

Subscribe to our news service on Telegram: [ Ссылка ]

Follow us:
CNA: [ Ссылка ]
CNA Lifestyle: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]

свернуть